SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193805-15-001598
Filing Date
2015-09-18
Accepted
2015-09-18 09:30:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 e614119_424b3-akari.htm 424B3 135548
  Complete submission text file 0001193805-15-001598.txt   136715
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 424B3 | Act: 33 | File No.: 333-185197 | Film No.: 151114598
SIC: 2834 Pharmaceutical Preparations